Laserfiche WebLink
3.9 <br />3.10 <br />3.11 <br />3.12 <br />3.13 <br />3.14 <br />3.15 <br />3.16 <br />3.17 <br />3.18 <br />3.19 <br />3.20 <br />3.21 <br />3.22 <br />3.23 <br />3.24 <br />3.25 <br />3.26 <br />Title to and Condition of Real Property and Tangible Personal <br />38 <br />Property.................................................. <br />27 <br />28 <br />Intangibles................................................ <br />28 <br />Information Regarding the Systems ............................. <br />Taxes....................................................29 <br />Absence of Conflicting Agreements; Consents ....................36 <br />Employee Plans ............................................ <br />31 <br />Environmental laws........................................33 <br />Claims and Litigation........................................33 <br />Claims and Litigation........................................37 <br />Compliance With Laws......................................33 <br />4.6 <br />Transactions with Affiliates ................................... <br />34 <br />Certain Fees ............................................... <br />34 <br />inventory ................................................. <br />34 <br />Overbuilds; Competition.....................................34 <br />38 <br />Disconnections ................... ..........................35 <br />Financial Statements ........................................ <br />Year2000..........................4......................35 <br />5.10 <br />Budgets.........................................4.........35 <br />41 <br />SECReports.........................................4....435 <br />Cure ..................................................... <br />Foreign Comipt Practices Act.................................35 <br />Cure....................................4..........4.....35 <br />SECTION 4: REPRESENTATIONS AND WARRANTIES OF SELLERS ............... <br />38 <br />4.1 <br />Organization ............................................. <br />. 36 <br />36 <br />4.2 <br />Authorization and Binding Obligation ........................... <br />4.3 <br />Absence of Conflicting Agreements; Consents ....................36 <br />4.4 <br />Title to Purchased Interests...................................37 <br />4.5 <br />Claims and Litigation........................................37 <br />4.6 <br />Certain Fees...............................................37 <br />40 <br />4.7 <br />Investment Purpose; Investment Company ....................... <br />37 <br />4.8 <br />Cure ..................................................... <br />38 <br />SECTION 5: REPRESENTATIONS AND WARRANTIES OF BUYER ................ <br />38 <br />5.1 <br />Organization ............................................. <br />38 <br />5.2 <br />Authorization and Binding Obligation ........................... <br />5.3 <br />Absence of Conflicting Agreements; Consents ....................39 <br />5.4 <br />Claims and Litigation........................................39 <br />5.5 <br />Investment purpose; Investment Company .......................39 <br />5.6 <br />Ownership of Buyer and its Subsidiaries ......................... <br />40 <br />5.7 <br />Certain Fees ............................................... <br />40 <br />.. 5.8 <br />AvailabilityofFunds................. .... .................... <br />40 <br />5.9 <br />Financial Statements ........................................ <br />40 <br />5.10 <br />Private Offering Memorandum and S-4 .......................... <br />41 <br />_ <br />5.11 <br />Cure ..................................................... <br />41 <br />ocmmrus ei¢cuna+ <br />